| Literature DB >> 34113166 |
Abstract
OBJECTIVE: To describe minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for highly migrated lumbar disc herniation (LDH) and assess its clinical outcomes. PATIENTS AND METHODS: This research retrospectively assessed 25 patients who were diagnosed with one-segmental highly migrated LDH and underwent MIS-TLIF in Peking University First Hospital from June 2015 to September 2019. Demographic data, perioperative parameters, complications, recurrence, and surgical outcomes were assessed.Entities:
Keywords: clinical outcomes; highly migrated lumbar disc herniation; minimally invasive transforaminal lumbar interbody fusion
Year: 2021 PMID: 34113166 PMCID: PMC8187084 DOI: 10.2147/JPR.S303930
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Four anatomic zones and levels of disc herniation: ZONE 1, far-upward: from the inferior margin of upper pedicle to 3 mm underneath the inferior margin of upper pedicle; ZONE 2, near-upward: from 3 mm underneath the inferior margin of upper pedicle to the inferior margin of upper vertebral body; ZONE 3, near-downward: from the superior margin of lower vertebral body to the center of lower pedicle; ZONE 4, far-downward: from the center to the inferior margin of lower pedicle.
Figure 2A 43-year-old male diagnosed with L5/S1 highly migrated LDH who underwent MIS-TLIF: (A and B) Preoperative MRI revealed highly downward migrated disc herniation on L5/S1. (C) Anteroposterior and (D) lateral radiographs after MIS-TLIF and percutaneous pedicle screw fixation.
Demographic Characteristics (N = 25)
| Variables | |
|---|---|
| Age (years) | 56.68±10.13 |
| Sex: male (%) | 12 (48.00) |
| BMI (kg/m2) | 25.89±3.01 |
| Herniation level (n) | |
| L3/4 | 4 |
| L4/5 | 15 |
| L5/S1 | 6 |
| Conservative time (months) | 7.44±1.58 |
Abbreviation: BMI, body mass index.
Perioperative Parameters, Complications, and Recurrence
| Variables | |
|---|---|
| Operation time (minutes) | 222.16±42.46 |
| Intraoperative hemorrhage (mL) | 250.00±118.05 |
| Postoperative hospitalization (days) | 5.76±2.57 |
| Complication, n (%) | 1 (4.00) |
| Recurrence, n (%) | 0 (0) |
Clinical Outcomes
| Variables | |
|---|---|
| Preoperative | 7.20±0.76 |
| 1 months after operation | 3.00±0.65* |
| 6 months after operation | 1.80±0.41* |
| 12 months after operation | 1.12±0.33* |
| Preoperative | 7.00±0.71 |
| 1 months after operation | 2.68±0.63* |
| 6 months after operation | 1.96±0.61* |
| 12 months after operation | 0.96±0.45* |
| Preoperative | 28.12±1.92 |
| 1 months after operation | 15.20±1.15* |
| 6 months after operation | 12.24±0.97* |
| 12 months after operation | 10.72±0.68* |
| 22 (88.0) |
Note: *Statistically significant difference compared with preoperative baseline.
Abbreviations: VAS, visual analog scale; ODI, Oswestry disability index.